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Abstract
Background: To date more than 20 antigenically distinct strains of Orientia tsutsugamushi (OT) reported within the
tsutsugamushi triangle that cause an undifferentiated acute febrile illness in humans. Genotypic characterization of
OT in different geographic regions or within the same country, is important in order to establish effective
diagnostics, clinical management and to develop effective vaccines. Genetic and antigenic characterization of OT
causing human disease in OT-endemic regions is not known for Sri Lanka.
Methods: Adult patients and children who were admitted with an acute febrile illness and presumed to having
acute scrub typhus based on presence of an eschar and other supporting clinical features were recruited. Eschar
biopsies and buffy coat samples collected from patients who were confirmed having OT by IFA were further
studied by real time PCR (Orientia 47 kD) and nested PCR (Orientia 56 kD) amplification. DNA sequences were
obtained for 56 kD gene amplicons and phylogenetic comparisons were analyzed using currently available data in
GenBank [Neucleotide substitution per 100 residues, 1000 Bootstrap Trials].
Results: Twenty eschar biopsies (Location1,19, Location 2,1) and eight buffy coat samples (Location1,6, Location2,2)
examined by real time PCR revealed Orientia amplicons in 16 samples. DNA sequences were obtained for the 56 kD
gene amplicons in 12 eschars and 4 buffy coat samples. The genotypes of the Location1 samples revealed that, 7
exhibiting close homology with JP1 [distantly related to UT177 Thai (Karp related)], five had close homology with
Kato strain, two had close homology with JGv and JG AF [Distantly related to Kawasaki M63383] and one had close
homology with Gilliam strain. The Location 2 strain was closely related to Kuroki-Boryong L04956, the genotype
which is distributed in far eastern Asia. Similar to other patients in the cohort this patient also had never travelled
out of Sri Lanka.
Conclusions: We observed all three main OT genotypes in Sri Lanka, and the majority fell into Thai Karp related
clade. These results demonstrate great antigenic diversity of OT in the studied areas of Sri Lanka.
Keywords: Orientia tsutsugamushi, Scrub typhus, Genotypes, Sri Lanka
* Correspondence: ranjanp64@gmail.com; Isblanto@utmb.edu
1Department of Medicine, Faculty of Medicine, University of Kelaniya,
Thalagolla Road, PO Box 6, Ragama, Sri Lanka
2Division of Infectious Diseases, Department of Internal Medicine, University
of Texas Medical Branch, Galveston, TX, USA
Full list of author information is available at the end of the article
© The Author(s). 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Premaratna et al. BMC Infectious Diseases  (2017) 17:67 
DOI 10.1186/s12879-016-2165-z
Background
Scrub typhus (ST), or tsutsugamushi disease, is an acute
febrile illness in humans caused by infection with Orien-
tia tsutsugamushi (OT) following a bite of an infected
mite vector of the genus Leptotrombidium [1]. Scrub ty-
phus is endemic in the Asia-Pacific region, extending
from Afghanistan to China, Korea, the islands of the
western Pacific and Indian Oceans, and northern
Australia [2, 3]. This endemic region is often referred to
as the tsutsugamushi triangle, and hosts approximately 1
billion people [4]. The vectors can be found in a variety of
ecological conditions, from the mountainous regions of
northern India to the tropical climates of the Malay Penin-
sula and Indonesia [2]. Transovarial transmission of OT
within vectors appears to be essential to maintenance of
the agent in nature; thus, the mite serves as both the vec-
tor and the reservoir [2]. Transmission of the etiologic
agent to vertebrate hosts occurs during feeding of the
larval or “chigger” stage of mites [2]. While Orientia is
vertically maintained in Leptotrombidium mite popula-
tions, it may be transmitted horizontally from mites to
vertebrate hosts [2]. The transmission to humans is inci-
dental. Currently, there is no vaccine against ST [5].
The disease mimics several other tropical febrile illnesses,
and can vary from mild to fatal disease, with reported mor-
tality rates of 35%–50% during the pre-antibiotic era [6, 7]
to 7–9% currently, in different geographical regions [5]. Al-
though detection of eschars assists early diagnosis, the oc-
currence of this sign is highly variable and depends on the
host, geographical region, and possibly the bacterial strain
[8]. ST became more familiar during World War II, when
soldiers deployed to endemic regions were affected in great
numbers [2]. Research since World War II has highlighted
dramatic antigenic variation among strains of OT [2] Al-
though great inter-strain variability in virulence has been
shown in mouse models, it is not clear whether virulence
for mice can be directly applicable to humans [2]. How-
ever, the antigenic variation may result in a spectrum
of illness from very mild to disease that is often fatal
when untreated [2]. To date, 20 antigenically distinct
strains of OT have been reported, including the ini-
tially serologically distinguished prototypic strains
Karp, Gilliam, and Kato [9]. The introduction of
chloramphenicol and, later, the tetracyclines dramatic-
ally eliminated mortality among cases where treat-
ment was started early [10–12]. Although relapses
and reinfections occur [12], infection is generally re-
sponsive to treatment with antibiotics such as doxy-
cycline and azithromycin, even when antigenically
diverse strains are involved [2].
The documented history of scrub typhus in Sri Lanka
dates back to the Second World War [5]. Similar to
other countries in the tsutsugamushi triangle where
scrub typhus is endemic, Sri Lanka also experiences a
variable burden due to the illness. The incidence of the
disease seems to be based on human activity, and eco-
logical and climatic factors. Although OT in Sri Lanka is
confirmed with IFA-based diagnostic techniques, the
genotypic characterization of infecting OT strains is un-
known. Such genotypic characterization of OT is im-
portant to establish effective diagnostics and to develop
effective vaccines.
The current study was designed to identify the strains of
OT causing clinical illness in two areas along the western
coastal belt of Sri Lanka. Both areas (Fig. 1), which are ap-
proximately 100 km apart, are endemic for OT. They are
likely to have similar ecological characteristics, both are in
the wet zone and 5–10 km from the coast.
Methods
Paediatric and adult patients who presented with an acute
febrile illness to Balapitiya Base Hospital (Location 1) and
the Professorial Medical Unit of Colombo North Teaching
Hospital (Location 2) in Sri Lanka were examined clinic-
ally in order to identify an eschar; the essential inclusion
criteria for the study. Consecutive patients who fulfilled
the essential criteria (acute fever and an eschar) were re-
cruited for the study. For patients who were more than 18
years of age a punch biopsy of the eschar was performed
after obtaining informed written consent. For those who
were less than 18 years old, as they were considered not
competent for consenting according to the Sri Lankan
law, a 3 cc sample of blood was collected after obtaining
informed written consent from their guardians. Patients
who were considered severely ill, declined to consent, or
had received anti-rickettsial antibiotics for more than 24 h
were excluded from the study. Relevant demographic,
clinical, and laboratory data of all patients were collected
into a predesigned data collectionform.
Biopsy tissue and buffy coat samples were stored in
RNAlater (Life Technologies, Grand Island, NY) accord-
ing to the manufacturer’s instructions. The samples were
stored at−80°C until they were sent to the University of
Texas Medical Branch, Galveston, USA, for further ana-
lysis. The patients were further tested by serology to de-
tect IgG antibodies against Karp, Kato or Gilliam antigens
by IFA in order to confirm OT infection. The IFA-IgG test
was done using antigen coated slides procured from Fuller
Laboratories (Fullerton, California, USA) adhering to
manufacturer’s instructions.
Prior to processing, biopsy tissues stored in RNAlater
were rinsed in phosphate buffered saline (PBS). A sterile
scalpel blade was used to cut a one fourth sized wedge out
of each tissue sample for DNA extraction. The biopsy
wedges were placed in 2 mL microcentrifuge tubes with
200 μL of PBS and two 4 mm stainless steel grinding balls.
Tissues were homogenized with a Retsch MM300 mixer
mill (Bio-Rad, Hercules, CA) for 2 min at 30 Hz. DNA
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was extracted from the homogenate using the DNeasy
Blood and Tissue Kit (QIAGEN, Valencia, CA).
Buffy coat samples stored in RNAlater were centri-
fuged in 2.0 mL microcentrifuge tubes at 5000 × g for 5
min. The supernatant was removed, and the remaining
cell pellet was resuspended in 200 μL of PBS with 200
μL of lysis buffer (QIAGEN). DNA was extracted using
the DNeasy Blood and Tissue Kit.
Real time PCR was performed on extracted DNA
using primers designed to amplify a segment of the
Orientia 47-kD antigen gene (Additional file 1: Table
S1). [13] Of the samples positive for OT DNA, nested
PCR to amplify a portion of the 56-kD protein gene was
performed as previously described (Additional file 1:
Table S1). [14] PCR amplicons were cloned using chem-
ically competent E. coli cells and the TOPO TA Cloning
Kit (Life Technologies). Plasmid DNA was purified with
the PureLink Plasmid Miniprep Kit (Life Technologies)
and sequenced using a 3130xl Genetic Analyzer (Life
Technologies).
The partial 56-kD sequences were trimmed of primer
sequences using EditSeq of the Lasergene Core Suite
software version 12.0 (DNASTAR, Madison, WI) and
then identified by comparing them with sequences avail-
able in GenBank via BLAST database search (http,//blas-
t.ncbi.nlm.nih.gov). Phylogenetic analyses of the study
and reference sequences were performed using MegA-
lign of the Lasergene Core Suite (DNASTAR). Sequence
alignment was performed using CLUSTAL W, and a
phylogenetic tree was constructed with 1,000 bootstrap
replications using the neighbor-joining method. For resi-
due conservation analysis, nucleotide sequences were
translated from open reading frames of DNA sequences
using EditSeq. These nucleotide sequences were then
aligned and analyzed using MegAlign.
Results
During the period of six months from January - August
2013, 19 eschar biopsies and 6 buffy coat samples were
collected from study site 1 (Balapitiya), and 1 eschar
biopsy and 2 buffy coat samples were collected from
study site 2 (Ragama). Real time PCR for the Orientia
47-kD protein gene showed amplicons in 16 samples
(15/25 at study site 1 and 1/3 at study site 2). Of those
Fig. 1 A map of Sri Lanka to highlight the geographical locations of the two study sites
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positive by real time PCR, nested PCR for the 56-kD
gene amplified DNA from 12 eschars and 4 buffy coat
samples (Additional file 2: Figure S1).
The genotypes of the Location 1 samples showed that
seven exhibited close homology with JP1 [distantly re-
lated to UT177 Thai (Karp-related)], five had close hom-
ology with Kato strain, two had close homology with
JGv and JG AF [distantly related to Kawasaki M63383],
one had close homology with Gilliam strain. The Loca-
tion 2 strain was closely related to Kuroki-Boryong
L04956 (Fig. 2).
Alignment and residue conservation analysis of the nu-
cleotide sequences demonstrated that genotypic differences
between samples conferred nucleotide heterogeneity, which
could result in antigenic variation in the studied region
(Additional file 3: Figure S2 and Additional file 4: Figure S3).
Discussion
Originally, three distinctive antigenic prototypes of OT
(Karp, Kato, and Gilliam) were described using serologic
testing (via complement fixation) [15]. The serologic di-
versity is based largely on the 56-kDa type specific anti-
gen (TSA), [16]. Later, over 20 additional strains of OT
were found [9] by indirect immunofluorescence assays
(IFA) using strain- or type-specific monoclonal anti-
bodies or hyperimmune sera which recognize the 56-
kDa TSA and by the genetic sequences of this genetically
diverse protein. Recent efforts to catalog the strains
present in various locations have identified novel
subtypes. Multi-locus sequence typing (MLST) analysis
of Thai isolates has shown a very high rate of recombin-
ation, which along with gene duplication and horizontal
gene transfer accounts for the genetic diversity among
OT isolates in various locations of Thailand [17, 18].
An increased prevalence of Karp and Karp-like strains
has been reported in the Southeast Asian countries, in-
cluding Malaysia (56%), Thailand (65%), Myanmar (46%),
and Philippines (78%) [19–21], Boryong is the predomin-
ant strain reported from Korea [22]. However, several
studies in India have reported a high prevalence of Kato-
like organisms (65%) and the majority have sequence simi-
larity with OT isolates from Korea, Thaiwan, Vietnam and
Cambodia [23]. Around 35% were Karp-like, and the rest
were related to Kawasaki and Gilliam types.
This is the first study from Sri Lanka to describe the
genotypes of OT, in two geographical areas that are
about 100 km apart along the western coastal belt within
the wet zone of Sri Lanka with probably similar eco-
logical conditions. We were able to recruit 25 patients
from study site 1 and 3 patients in study site 2 during
the 6 months of the study. However, there were only 15/
25 at study site 1 and 1/3 at study site 2 were positive by
real time PCR, nested PCR for the 56-kD gene. The pa-
tients who were negative by PCR fulfilled criteria for re-
cruitment to the study and had very high IFA-IgG titres
against Orientia antigens. However, it is very likely that
they had either received anti-rickettsial antibiotics prior
to admission to hospital by the general practitioners or
Fig. 2 Phylogenetic tree to demonstrate the genetic relationship of O. tsutsugamushi isolates from the two study sites
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were recruited at a very late stage of the infection and
therefore had already cleared the agent from their blood
or tissues.
Although the study included only 16 positive samples,
it is interesting to note that we have observed great gen-
etic diversity of OT within the relatively small geograph-
ical areas that were studied. In contrast to what has
been reported from India, but similar to reports from
southeastern parts of Asia, we noted a slightly higher
prevalence of Karp [Thai-related] genotypes followed by
Kato-related, Kawasaki-related and Gilliam-related geno-
types. However, it is interesting to note the close
homology with the Kuroki-Boryong organism in one
patient from study site 2 (Ragama) who, like the
others, had never travelled out of Sri Lanka. The main
limitation of this study is that it was carried out over a short
period of 6 months and included only 16 positive samples
(15 from study site 1 and only 1 from study site 2). Al-
though we observed a close temporal distribution of geno-
types within the 6 months, a longer study recruiting more
epidemiologically representative samples, is likely to give
more insight into the pattern of circulation of the different
strains of O. tsutsugamushi in the two selected geographical
regions. Design of such a study requires an epidemiological
survey of the two study sites in order to understand the
exact prevalence of this re-emerging infection in the two
areas – such data is currently lacking.
A 2011 study in Korea comparing the clinical severity
between Boryong and Karp genotypes suggested that es-
chars and rashes were found in 97% and 94% of the pa-
tients infected with the Boryong cluster compared to
73.7% and 68.4% of the patients infected with the Karp
cluster, respectively, suggesting clinical variation among
infections with different serotypes of OT [24]. In a previ-
ous study conducted in the same geographical region,
we found a high eschar detection rate (89%) that is in
keeping with the above findings [25].
Since this study analyzed only 16 positive samples, it is
difficult to arrive at conclusions on the complete com-
position of OT genotypes in Sri Lanka. However, since
Sri Lanka has diverse ecological and environmental con-
ditions within the matter of 2–3 h travel, a larger scale
study that covers all ecological zones could contribute to
understanding of the complex diversity of OT infection
and its transmission within the country.
Conclusions
We observed five genotypes of O. tsutsugamushi demon-
strating great genetic diversity in relatively small geo-
graphic areas of Sri Lanka, with the majority falling into
the Karp-related clade. We believe that such knowledge
will contribute to potential prediction of clinical illness,
production of future diagnostic tests, and development
of vaccines.
Additional files
Additional file 1: Table S1. Primers designed to amplify a segment of
the Orientia 47-kD antigen gene and a portion of the 56-kD protein gene.
(DOCX 14 kb)
Additional file 2: Figure S1. Example of representative PCR amplicons
on a 1% DNA agarose gel. Lane 1, 100 bp DNA ladder; lane 2, eschar #8
(Karp-related); lane 3, eschar #2 (Kato-related); lane 4, eschar #12 (Gilliam-
related); lane 5, negative control; lane 6, Karp strain positive control; lane 7,
Kato strain positive control; lane 8, Gilliam strain positive control. (JPG 9 kb)
Additional file 3: Figure S2. Analysis of nucleotide sequence alignment
showing the percent identity and divergence as each eschar and buffy
coat nucleotide sequence is compared to one another. (JPG 121 kb)
Additional file 4: Figure S3. Graphical report showing matching versus
differing residues within the nucleotide sequence alignment generated
from eschars and buffy coats. (JPG 210 kb)
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